Marla Weetall

4.7k total citations
70 papers, 1.2k citations indexed

About

Marla Weetall is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Marla Weetall has authored 70 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Molecular Biology, 14 papers in Oncology and 10 papers in Cancer Research. Recurrent topics in Marla Weetall's work include RNA modifications and cancer (10 papers), Biochemical and Molecular Research (9 papers) and Cancer Cells and Metastasis (6 papers). Marla Weetall is often cited by papers focused on RNA modifications and cancer (10 papers), Biochemical and Molecular Research (9 papers) and Cancer Cells and Metastasis (6 papers). Marla Weetall collaborates with scholars based in United States, Switzerland and Japan. Marla Weetall's co-authors include Thomas W. Davis, David Holowka, Barbara Baird, Josephine Sheedy, Liangxian Cao, Sergey Paushkin, Nikolai A. Naryshkin, Hasane Ratni, Ellen Welch and Manisha Mone and has published in prestigious journals such as Journal of Clinical Oncology, Blood and The Journal of Immunology.

In The Last Decade

Marla Weetall

68 papers receiving 1.2k citations

Peers

Countries citing papers authored by Marla Weetall

Since Specialization

Citations

This map shows the geographic impact of Marla Weetall's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marla Weetall with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marla Weetall more than expected).

Fields of papers citing papers by Marla Weetall

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marla Weetall. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marla Weetall. The network helps show where Marla Weetall may publish in the future.

Co-authorship network of co-authors of Marla Weetall

This figure shows the co-authorship network connecting the top 25 collaborators of Marla Weetall. A scholar is included among the top collaborators of Marla Weetall based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marla Weetall. Marla Weetall is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Phase Ib Study of Unesbulin (PTC596) Plus Dacarbazine for the Treatment of Locally Recurrent, Unresectable or Metastatic, Relapsed or Refractory Leiomyosarcoma 2024 ·Journal of Clinical Oncology ·Brian A. Van Tine, Matthew Ingham, Steven Attia, Christian F. Meyer, John D. Baird, Esther M. Brooks-Asplund, (unknown), Ronald Kong, Anthony Mwatha, (unknown), Marla Weetall, Robert J. Spiegel, Gary K. Schwartz	3
2	Emvododstat, a Potent Dihydroorotate Dehydrogenase Inhibitor, Is Effective in Preclinical Models of Acute Myeloid Leukemia 2022 ·Frontiers in Oncology ·Arthur Branstrom, Liangxian Cao, Bansri Furia, Christopher R. Trotta, Marianne Santaguida, Jason D. Graci, Joseph M. Colacino, Balmiki Ray, Wencheng Li, Josephine Sheedy, Anna Mollin, Shirley Yeh, Ronald Kong, Richard Brinsley Sheridan, John D. Baird, (unknown), Robert J. Spiegel, Elizabeth Goodwin, (unknown), Marla Weetall	10
3	The Novel Dihydroorotate Dehydrogenase (DHODH) Inhibitor PTC299 Inhibit De Novo Pyrimidine Synthesis with Broad Anti-Leukemic Activity Against Acute Myeloid Leukemia 2020 ·Blood ·Sujan Piya, Marla Weetall, Josephine Sheedy, Balmiki Ray, Huaxian Ma, Kensuke Kojima, Vivian Ruvolo, (unknown), Marina Konopleva, Michael Andreeff, Gautam Borthakur	0
4	Chemical modifications of G418 (geneticin): Synthesis of novel readthrough aminoglycosides results in an improved in vitro safety window but no improvements in vivo 2020 ·Carbohydrate Research ·Ramil Baiazitov, Westley J. Friesen, Briana Johnson, Anna Mollin, Josephine Sheedy, (unknown), Marla Weetall, Arthur Branstrom, Ellen Welch, Young‐Choon Moon	6
5	Effective Delivery of a Microtubule Polymerization Inhibitor Synergizes with Standard Regimens in Models of Pancreatic Ductal Adenocarcinoma 2019 ·Clinical Cancer Research ·(unknown), Irina R. Sagalovskiy, H. Carlo Maurer, Stephen A. Sastra, Carmine F. Palermo, Amanda R. Decker-Farrell, Min Jung Kim, Josephine Sheedy, Anna Mollin, Liangxian Cao, Jianhua Hu, Arthur Branstrom, Marla Weetall, Kenneth P. Olive	18
6	ELP1 Splicing Correction Reverses Proprioceptive Sensory Loss in Familial Dysautonomia 2019 ·The American Journal of Human Genetics ·Elisabetta Morini, Dadi Gao, (unknown), Monica Salani, (unknown), (unknown), (unknown), Paula Dietrich, Jana Narasimhan, Vijayalakshmi Gabbeta, Amal Dakka, Jean Hedrick, Xin Zhao, Marla Weetall, Nikolai A. Naryshkin, Gregory R. Wojtkiewicz, Chien-Ping Ko, Michael E. Talkowski, Ioannis Dragatsis, Susan A. Slaugenhaupt	26
7	Inhibition of BMI1, a Therapeutic Approach in Endometrial Cancer 2018 ·Molecular Cancer Therapeutics ·(unknown), Anindya Dey, Shailendra Kumar Dhar Dwivedi, (unknown), Kai Ding, Roy Zhang, Priyabrata Mukherjee, Kathleen N. Moore, Liangxian Cao, Arthur Branstrom, Marla Weetall, John D. Baird, Resham Bhattacharya	14
8	Risdiplam distributes and increases SMN protein in both the central nervous system and peripheral organs 2018 ·Pharmacology Research & Perspectives ·Agnès Poirier, Marla Weetall, Katja Heinig, Franz Bucheli, (unknown), Jochem Alsenz, (unknown), Mohammed Ullah, Claudia Senn, Hasane Ratni, Nikolai A. Naryshkin, Sergey Paushkin, Lutz Mueller	114
9	Relationship Between Central and Peripheral SMN Protein Increase Upon Treatment with RO7034067 (RG7916) (S46.007) 2018 ·Neurology ·Agnès Poirier, Marla Weetall, Hasane Ratni, Katja Heinig, Nikolai A. Naryshkin, Sergey Paushkin, Lutz Mueller	1
10	Preclinical Evaluation of the First in Class BMI1 Inhibitor PTC-028 Confirms Potent Efficacy to Target BMI1-Addiction in Multiple Myeloma 2017 ·Blood ·Arnold Bolomsky, Roy Heusschen, (unknown), Joséphine Muller, Marla Weetall, (unknown), Niklas Zojer, Jo Caers, Heinz Ludwig	1
11	PTC299 Is a Novel DHODH Inhibitor That Modulates VEGFA mRNA Translation and Inhibits Proliferation of a Broad Range of Leukemia Cells 2017 ·Blood ·Liangxian Cao, Arthur Branstrom, John D. Baird, Christopher R. Trotta, Joseph M. Colacino, (unknown), (unknown), Mark Ma, Kensuke Kojima, Stuart W. Peltz, Edward O’Mara, Robert J. Spiegel, Marla Weetall	1
12	The nucleoside analog clitocine is a potent and efficacious readthrough agent 2017 ·RNA ·Westley J. Friesen, Christopher R. Trotta, (unknown), Jin Zhuo, Briana Johnson, (unknown), Bijoyita Roy, Marla Weetall, Jean Hedrick, Josephine Sheedy, (unknown), Young‐Choon Moon, Suresh Babu, Ramil Baiazitov, John Leszyk, Thomas W. Davis, Joseph M. Colacino, Stuart W. Peltz, Ellen Welch	36
13	Identification of benzazole compounds that induce HIV-1 transcription 2017 ·PLoS ONE ·Jason D. Graci, (unknown), Guangming Chen, Gillian M. Schiralli Lester, (unknown), Marla Weetall, Gary M. Karp, Zhengxian Gu, Joseph M. Colacino, Andrew J. Henderson	2
14	Initial first-in-human phase 1 results of PTC596, a novel small molecule that targets cancer stem cells (CSCs) by reducing BMI1 protein levels 2016 ·Annals of Oncology ·Geoffrey I. Shapiro, Jon Infante, Todd M. Bauer, Amy Prawira, (unknown), O. L. Laskin, Marla Weetall, John D. Baird, Edward O’Mara, Robert J. Spiegel	2
15	Discovery of 2-(4-sulfonamidophenyl)-indole 3-carboxamides as potent and selective inhibitors with broad hepatitis C virus genotype activity targeting HCV NS4B 2015 ·Bioorganic & Medicinal Chemistry Letters ·Nanjing Zhang, Anthony Turpoff, Xiaoyan Zhang, Song Huang, Yalei Liu, Neil G. Almstead, F. George Njoroge, Zhengxian Gu, Jason D. Graci, (unknown), John Pichardo, Joseph M. Colacino, Frederick Lahser, Paul Ingravallo, Marla Weetall, Amin A. Nomeir, Gary M. Karp	10
16	Discovery of N-(4′-(indol-2-yl)phenyl)sulfonamides as novel inhibitors of HCV replication 2013 ·Bioorganic & Medicinal Chemistry Letters ·Guangming Chen, Hongyu Ren, Anthony Turpoff, Alexander Arefolov, (unknown), (unknown), Atiyya R. Khan, Neil G. Almstead, Zhengxian Gu, Takashi Komatsu, (unknown), Jamie J. Breslin, Joseph M. Colacino, Jean Hedrick, Marla Weetall, Gary M. Karp	15
17	BMI1 as a novel target for drug discovery in cancer 2011 ·Journal of Cellular Biochemistry ·Liangxian Cao, (unknown), (unknown), Josephine Sheedy, Marla Weetall, Thomas W. Davis	117
18	Blockade of Integrin VLA-4 Prevents Inflammation and Matrix Metalloproteinase Expression in a Murine Model of Accelerated Collagen-Induced Arthritis 2003 ·Inflammation ·(unknown), Mary Chou, Marla Weetall, Arco Y. Jeng	11
19	A Homogeneous Fluorometric Assay for Measuring Cell Adhesion to Immobilized Ligand Using V-Well Microtiter Plates 2001 ·Analytical Biochemistry ·Marla Weetall, Ronald J. Hugo, (unknown), Susan West, Sompong Wattanasin, (unknown), Gabriele Weitz‐Schmidt, (unknown), Constance L. Friedman	38
20	Design and Synthesis of Potent and Selective Inhibitors of Integrin VLA-4 2001 ·Bioorganic & Medicinal Chemistry Letters ·Sompong Wattanasin, Beat Weidmann, Didier Roche, (unknown), (unknown), (unknown), Michael Sabio, Peter Matt, Ronald J. Hugo, (unknown), (unknown), Marla Weetall	11

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact